Solvay’s sales rose +4% (v: +9%; p: 0%; FX: -4%; portfolio: -1%) to €2,464m in Q3, but the gross profit margin declined from 31.6% to 30.8%. EBITDA declined 3% to €499m and net income attributable to shareholders came in pretty much unchanged at €179m (€176m). benefiting from a tax income. Mainly due to the tax income (€-90m after €30m) and a swing in NWC (€-34m after €27m), operating CF strongly fell by 22% to €406m. After the previous year&
08 Nov 2017
Good top-line performance, but impairments are heavy weight
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Good top-line performance, but impairments are heavy weight
Solvay SA (SOLB:WBO) | 0 0 0.5% | Mkt Cap: 11,953m
- Published:
08 Nov 2017 -
Author:
Martin Schnee -
Pages:
3
Solvay’s sales rose +4% (v: +9%; p: 0%; FX: -4%; portfolio: -1%) to €2,464m in Q3, but the gross profit margin declined from 31.6% to 30.8%. EBITDA declined 3% to €499m and net income attributable to shareholders came in pretty much unchanged at €179m (€176m). benefiting from a tax income. Mainly due to the tax income (€-90m after €30m) and a swing in NWC (€-34m after €27m), operating CF strongly fell by 22% to €406m. After the previous year&